Despite its growing “deeptech” bonafides, the US neurotechnology industry has wound up on the wrong side of AI.
The Centers for Medicare and Medicaid Services (CMS) announced a new pilot program to test whether AI-enabled claim denials will save money. How? By automatically reducing the use…